AECOM (ACM) vs The Timken Company (TKR)
AECOM and The Timken Company side by side — fundamentals from SEC filings, refreshed nightly. Sector: Industrials.
AI verdict — ACM vs TKR, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| AECOM (ACM) | The Timken Company (TKR) | |
|---|---|---|
| Market cap | $8.8B | $9.3B |
| Revenue (latest FY) | $16.14B | $4.58B |
| Net income (latest FY) | $561.77M | $288.40M |
| Revenue growth (5y CAGR) | 4.0% | 5.5% |
| Net margin | 3.5% | 6.3% |
| Return on equity | 22.5% | 9.1% |
| P/E ratio | 14.4 | 30.3 |
| Dividend yield | 1.7% | 1.1% |
| Profitable years (of last 10) | 8 | 10 |
| Positive free cash flow | Yes | Yes |
Performance — ACM vs TKR
Total returns from monthly split- and dividend-adjusted closes; 52-week range from the latest quote. Past performance is not a prediction.
| AECOM (ACM) | The Timken Company (TKR) | |
|---|---|---|
| 1-year return | -38.4% | 86.3% |
| 3-year return | -16.3% | 52.8% |
| 5-year return | 13.3% | 79.7% |
| 10-year return | 125.9% | 430.8% |
| 52-week range | $67.64–$135.52 | $69.26–$139.77 |
Verify the comparison
Use the filing period and source shown by each tool before treating two figures as comparable.
See the full ACM vs TKR breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open ACM's full financials → Open TKR's full financials →Frequently asked questions
Which is bigger, ACM or TKR?
The Timken Company is larger by market capitalization — $9.3B versus $8.8B.
Which grows faster, ACM or TKR?
Over the last five fiscal years, The Timken Company grew revenue faster — 5.5%/yr versus 4.0%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.